IL17A and cancer: Abnormal activation of the PI3K/Akt pathway resulted in the survival and proliferation of tumour cells in various human cancers.50 Our results showed that IL‐17A increased both phosphorylated protein levels of PI3K (Tyr458) and AKT (Ser473), indicating the activation of PI3K/AKT pathway.